| 000 | 01695 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517174926.0 | ||
| 264 | 0 | _c20180627 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1473-558X | ||
| 024 | 7 |
_a10.1097/WNR.0000000000000888 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNayak, Vanishri S | |
| 245 | 0 | 0 |
_aThe effects of Mucuna pruriens extract on histopathological and biochemical features in the rat model of ischemia. _h[electronic resource] |
| 260 |
_bNeuroreport _cDec 2017 |
||
| 300 |
_a1195-1201 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
| 650 | 0 | 4 |
_aCatalase _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMaze Learning _xdrug effects |
| 650 | 0 | 4 |
_aMucuna _xchemistry |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aPlant Extracts _xtherapeutic use |
| 650 | 0 | 4 |
_aQuercetin _xtherapeutic use |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSulfhydryl Compounds _xmetabolism |
| 650 | 0 | 4 |
_aSuperoxide Dismutase _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aKumar, Nitesh | |
| 700 | 1 | _aD'Souza, Antony S | |
| 700 | 1 | _aNayak, Sunil S | |
| 700 | 1 | _aCheruku, Sri P | |
| 700 | 1 | _aPai, K Sreedhara Ranganath | |
| 773 | 0 |
_tNeuroreport _gvol. 28 _gno. 18 _gp. 1195-1201 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/WNR.0000000000000888 _zAvailable from publisher's website |
| 999 |
_c27607120 _d27607120 |
||